Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the efficacy of etanercept 50 mg once weekly with SSZ 3 g daily in the treatment of AS subjects over 16 weeks. The study hypothesis is that etanercept 50 mg once weekly will demonstrate superior clinical efficacy, as determined by the proportion of responders achieving a 20% improvement on the Assessment of AS (ASAS) response criteria (ASAS 20; Attachment 2) at 16 weeks, compared with SSZ 3 g daily in the treatment of AS subjects.
Critère d'inclusion
- Subjects with Ankylosing Spondylitis (AS)